Start-up EBViously founded

Innovative vaccine based on virus-like particles

18-Dec-2024 - EBViously, a spin-off of Helmholtz Munich, officially started operations on 11 November 2024. The company is developing a preventive vaccine against diseases caused by the Epstein-Barr virus (EBV). The aim is to protect people from a range of serious diseases such as infectious mononucleosis, ...

Unlocking worm strategies: A pathway to innovative vaccines and therapies

The discovery opens new avenues for addressing global health challenges

10-Dec-2024 - A research team led by Prof. Julia Esser-von Bieren from the Center of Allergy and Environment (ZAUM) at Helmholtz Munich and the Technical University of Munich, as well as the University of Lausanne (UNIL) has uncovered a molecular strategy employed by worm parasites (helminths) to evade host ...

Ceva Animal Health invests in new 7,000 m² vaccine manufacturing facility to expand global production capacity

26-Nov-2024 - Ceva Animal Health (Ceva) unveils its latest investment in European vaccine manufacturing, with the construction of a new facility in Hungary, expanding the capacity of Ceva Phylaxia. This development will establish a 7,000 m2 plant in Monor, Hungary withthe most advanced technologies,where Ceva ...

Small German start-up develops bluetongue virus vaccine within a few months

Verovaccines leverages its new capabilities for rapid emergency response and cost-effective classical animal health vaccine development

09-Oct-2024 - The German vaccine specialist Verovaccines has shown how to go from a simple BTV-3 virus sequence to a validated vaccine in just a few months. In addition, an approval dossier has been created, which is now around 90% complete. The company expects to receive emergency use authorization before the ...

Vicebio Announces $100 Million Series B Financing

Funding will support and accelerate development of next-generation multivalent respiratory virus vaccines

30-Sep-2024 - Vicebio Ltd, a biopharmaceutical company developing novel vaccines against life-threatening respiratory viral infections, announces a $100 million Series B financing led by TCGX with investment from Goldman Sachs Alternatives, Avoro Ventures, venBio, and participation from UniQuest and founding ...

Chemists mimic natural molecular structures: New possibility for vaccine development

Fluorinated sugar molecules as vaccine leads against meningitis B and C

28-May-2024 - Meningococci (Neisseria meningitidis) are disease-causing bacteria that cause life-threatening meningitis, or blood poisoning (septicaemia). There are a number of meningococcal variants worldwide, known as serogroups, and in Germany the Standing Committee on Vaccination (STIKO) recommends ...

CureVac and MD Anderson enter strategic collaboration to develop novel cancer vaccines

Collaboration aims to develop novel, off-the-shelf, mRNA-based cancer vaccines in selected hematological and solid cancers with high unmet medical need

17-Apr-2024 - CureVac N.V. and The University of Texas MD Anderson Cancer Center announced a co-development and licensing agreement to develop novel mRNA-based cancer vaccines. The collaboration creates strong synergies between CureVac’s unique end-to-end capabilities for cancer antigen discovery, mRNA design, ...

New study on the benefits of Covid-19 nasal spray vaccination

Another milestone reached: researchers work together with Swiss biotech start-up to further develop the vaccine

29-Feb-2024 - Rocketvax AG, together with the German Research Foundation (DFG), has financially supported a study carried out as part of a joint project of the Swiss National Science Foundation (SNSF, National Research Program “Covid-19,” NRP 78) and the German Research Foundation (DFG) “Recoding the ...

“Honey, I shrunk the cookbook” – New approach to vaccine development

Vaccine development aims at protecting as many people as possible from infections

28-Dec-2023 - Short protein fragments of pathogens, so-called epitopes, are seen as a promising new approach for vaccine development. In the scientific journal Cell Systems, bioinformaticians from Heinrich Heine University Düsseldorf (HHU) now present a method for identifying those epitopes that promise safe ...

Progress toward Improved Vaccines

Novel adjuvants assembled from a chemical construction set

04-Dec-2023 - To ensure that vaccines provide strong and lasting immunization, it is often necessary to supplement the actual vaccine (antigen) with additives that stimulate the immune system: adjuvants. Today, only a few substances have been approved for use as adjuvants. In the journal Angewandte Chemie, a ...